Xenon Pharmaceuticals Inc (XENE) — Long-term Investment Intensity
Xenon Pharmaceuticals Inc (XENE) has a Long-term Investment Intensity of 15.3% as of September 2025. Long-term investments of $92.99 Million represent 15.3% of total assets of $607.84 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Xenon Pharmaceuticals Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Xenon Pharmaceuticals Inc Long-term Investment Intensity (2022–2024)
This chart shows how Xenon Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 3 annual periods from 2022 to 2024. As of September 2025, the intensity stands at 15.3%, reflecting long-term investments of $92.99 Million against total assets of $607.84 Million USD. Explore XENE operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Xenon Pharmaceuticals Inc (2022–2024)
The table below presents the year-by-year Long-term Investment Intensity for Xenon Pharmaceuticals Inc from 2022 to 2024, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see XENE market cap overview.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 16.0% | $127.50 Million | $798.14 Million | ▼ -14.4 pp |
| 2023 | 30.3% | $292.79 Million | $964.80 Million | ▲ +13.3 pp |
| 2022 | 17.1% | $128.68 Million | $754.15 Million | — |